We report on two teenage girls presenting following significant paracetamol overdoses (428 g paracetamol). Both presented within 4 h of the overdose and both were treated with N-acetylcysteine, in accordance with the National Poisons Information Service protocol. Within 8 h of presentation both had developed significant hypokalaemia with serum potassium concentrations o3.0 mmol/L and were treated with intravenous potassium chloride. Potassium concentrations returned to within reference limits (43.5 mmol/L) after commencing potassium chloride supplementation. An audit of potassium concentrations in 254 patients presenting with significant paracetamol overdose (paracetamol 40.5 mmol/L) admitted through four A&E departments in the West of Scotland showed a significant decline in mean serum potassium from 3.9 mmol/L on admission to 3.6 mmol/L (P ¼ o0.001) over the next 36 h. The mechanism for this hypokalaemia in these two individuals is unclear, however regular monitoring of potassium is advocated in such patients during their initial treatment.
Introduction
Paracetamol (acetaminophen) is an over-the-counter analgesic that is safe and e¡ective at therapeutic doses. It is, however, the most common substance involved in self-poisoning cases in the UK, accounting for around 50% of all self-poisoning hospital admissions. 1 Patients who have taken a paracetamol overdose may remain asymptomatic for the ¢rst 24 h following ingestion, or may display non-speci¢c symptoms such as nausea and vomiting. Hepatic damage is not normally symptomatic until at least 24 h post-overdose and is characterised initially by right upper quadrant abdominal pain. Late symptoms associated with severe liver damage may include jaundice, hypoglycaemia, hepatic encepholopathy and renal failure. 2 Paracetamol is principally inactivated in the liver by glucuronidation and sulphation and excreted in the urine. About 5--10% of a therapeutic dose is oxidised by cytochrome p450 enzymes to produce N-acetyl-p-benzoquinoneimine (NAPQI), a reactive electrophile which forms covalent bonds with hepatic cellular proteins, causing hepatotoxicity. Fortunately this toxic metabolite is inactivated by glutathione conjugation if therapeutic doses are ingested.When paracetamol is taken in overdose, the glucuronidation and sulphation pathways are saturated, and a greater proportion of the drug is converted to NAPQI, which overloads glutathione inactivation. N-acetylcysteine (NAC) is a speci¢c antidote for paracetamol poisoning which acts as a glutathione donor, promoting hepatic synthesis of glutathione and non-toxic metabolism. NAC is e¡ective when administered within 24 h of ingestion; it is most e¡ective when administered within 8 h. 3 If a patient develops hepatic failure, liver transplant is maybe the only e¡ective treatment to salvage life.
Case reports Patient A
Patient A, a 15-year-old girl, presented to the Accident & Emergency Department (A&E). She had a history of self-harm and had previously been admitted following overdoses of thyroxine, sertraline and allopurinol. She had vomited twice prior to her admission and had been brought in by her father based on her previous history. On admission she admitted to taking 96 tablets (48 g) of paracetamol three hours earlier. Serum paracetamol was measured at 2.1mmol/L,3 h 45 min after ingestion and she was started on an NAC infusion. NAC was given at 150 mg/kg over 15 min, then 50 mg/kg over 4 h, then 100 mg/kg over 16 h (patient weight ¼ 48 kg). At this time her serum potassium, measured by indirect ion selective electrode (ISE) was 3.9 mmol/L (see Table 1a ).
Blood samples were repeated 3 h into the NAC infusion and her serum potassium was found to have dropped to 2.8 mmol/L. It was noted that she would require potassium supplementation, which was, however, not prescribed at this point. The following morning potassium was measured at 2.3 mmol/L and at this point the decision was taken to temporarily stop her NAC infusion. Intravenous (IV) KCl was given, 4.8 mmol KCl in 5% dextrose, at 240 mL/h over 5 h. Following this IV KCl, the NAC infusion was restarted, she was started on oral potassium (Sando-K 24 mmol of potassium per day) and her serum potassium was measured as 2.9 mmol/L. Five hours later potassium had increased to 3.3 mmol/L. She made a full recovery and was discharged after 6 days. Further episodes of hypokalaemia were not observed.
Patient B
Patient B, a 14-year-old girl, presented four weeks after Patient A. She had no history of self-harm, however empty packets found suggested that she had consumed 56 tablets (28 g) of paracetamol. Two and a half hours after doing so, she admitted her actions and presented to hospital. On admission, blood paracetamol was measured at 2.2 mmol/L, approximately 3 h 30 min after ingestion. Treatment with NAC was started using the same protocol as Patient A (patient weight ¼ 54 kg). At this time her serum potassium concentration was 3.2 mmol/L (see Table 1b ).
Five hours into the NAC infusion, blood was taken and her paracetamol measured; this had reduced to 0.83 mmol/L. However at this point she had become hypokalaemic (serum potassium measuring 2.6 mmol/L). Over the next 30 h, she received 70 mmol of KCl in 5% dextrose IVand on completion of the NAC/dextrose/KCl infusion, her serum potassium concentration was 4.1mmol/L. Like patient A, she recovered and was discharged after 3 days.
Prevalence of hypokalaemia in significant paracetamol overdose
We retrospectively carried out a short audit to ascertain whether this observed hypokalaemia was common after paracetamol overdose. This was carried out by looking at the biochemistry results of individuals admitted through the emergency departments of Wishaw General Hospital in Lanarkshire, Glasgow Royal In¢rmary, the Western In¢rmary and Stobhill Hospital in Glasgow during the 12-month period from January to December 2005. Serum potassium results were reviewed on 254 individuals (88 men; 166 women) whose baseline paracetamol concentration was Z0.6 mmol/L (83.3 mg/L). Baseline admission potassium concentration was recorded, as was the lowest concentration observed over the next 36 h. Two hundred and three individuals (56 men and 147 women) (80% of total) showed a decrease in potassium concentration during this period and the mean potassium concentration fell from 3.9 mmol/L to 3.6 mmol/L (P ¼ o0.001, paired t-test). Men showed a mean decrease from 4.0 mmol/L to 3.7 mmol/L while women showed a decrease from 3.9 mmol/L to 3.5 mmol/L, however no signi¢cant di¡erence was observed between the groups (P ¼ 0.432, independent sample t-test) suggesting that both sexes respond in a similar way. 
Discussion
Two very similar cases are presented where serum potassium was found to fall signi¢cantly following a large paracetamol overdose. This raised the question as to the possible mechanism for this action. A retrospective study of 60 patients recently showed a signi¢cant negative correlation between admission paracetamol concentration and a fall in serum potassium, 4 this trend was con¢rmed in our audit of 254 individuals which showed a signi¢cant decrease in potassium of 0.3 mmol/L during the ¢rst 36 h after admission. Paracetamol has long been shown to have prostaglandin inhibitory properties at high concentrations (40.66--1.32 mmol/L). 5 It has been shown to have cyclo-oxygenase (COX) inhibitory activity and studies have shown that it can inhibit COX-2 in a systemic manner similar to that of selective COX-2 inhibitors such as celecoxib and rofecoxib. 6 In overdose, non-steroidal anti-in£ammatory drugs (NSAIDs) which have similar prostaglandin inhibitory properties can cause a dose dependant hypokalaemia as a result of renal vasoconstriction. 7 Vasoconstriction results in decreased renal perfusion and this in turn stimulates an increase in aldosterone production, via the renin-angiotensin axis, causing the distil tubules of the kidney to stimulate fractional sodium retention and potassium excretion. Paracetamol could therefore reduce the circulating potassium concentration as a secondary consequence of prostaglandin inhibition resulting in dose dependent renal potassium wasting (Bateman DN, personal communication). This e¡ect of renal potassium wasting and sodium retention, post overdose has recently been demonstrated in vivo in rats and is a possible mechanism underlying this phenomena. 8 The hypokalaemia could also partially be a consequence of stress induced cortisol elevation. Stress induced by controlled hypoglycaemia following an insulin stress test has been shown to produce overt hypokalaemia. 9 Both girls were most likely to be extremely stressed when admitted and this response cannot be excluded as a possible cause of the hypokalaemia.
In our two cases, however, interpretation is complicated by the amount of £uids given during NAC therapy. The protocol used within Lanarkshire is that published by the National Poisons Information Service, 10 which recommends NAC be given over 20 h 15 min in a total volume of 1700 mL of 5% dextrose. Such IV regimens, combined with oral £uid intake, will no doubt cause some electrolyte imbalance and hence confuse the interpretation of this data. Changes in the acid/base status of such patients, whilst relatively stable in the two patients described, may also have been a cause of £uctuations in potassium concentrations in the audited sample population, as elevated lactate and metabolic acidosis is common after ingestion of large doses of paracetamol. 11 How frequent is hypokalaemia in paracetamol overdose? A large proportion (80%) of patients studied showed a fall in serum potassium to a concentration below that of their baseline value within the ¢rst 36 h of their admission. The signi¢cant changes observed in the two girls described may be exacerbated by their slight build and lower volume of distribution than in the average population, however their lower than average body masses may also predispose these individuals' serum electrolytes to change to a greater extent in response to the £uid load given during NAC therapy.
We recommend that although the mechanism for the hypokalaemia following paracetamol overdose is unclear, regular serum potassium measurements should be carried out over the ¢rst 36 h after ingestion. Any signi¢cant hypokalaemia observed should be treated accordingly.
